How to file the license for drug network sales?
1
According to the "Supervision and Administration of Pharmaceutical Network Sales", the seller of drugs on the network should be a drug manufacturer, drug wholesaler, drug retail chain enterprises that have obtained the qualification of drug production and operation. Therefore, there is no network sales license, the next step is to introduce the process of drug retail enterprise license.
2
Log in as a legal person to the district-level government service website where the enterprise is registered
3. In the departmental navigation bar, select the business acceptance department "District Market Supervision Bureau".
4
In the keywords of the business accepted by the department, select "drug supervision".
5
In the specific drop-down list of business, select "drug business (retail) enterprises (chain stores, single-pharmacy) to prepare for the establishment", click on the right side of the "online"
6. In the jump business, view The conditions required to handle the business
7
In the declaration system, according to the guidance prompts to complete the registration of relevant information and uploading of data, and then submit to complete the corresponding application.
How is the reimbursement process for negotiated drugs?
Response: The National Health Security Bureau, in conjunction with the Ministry of Human Resources and Social Security, organized experts in accordance with the procedures for access negotiations on the national health insurance drug directory, the successful negotiation of drugs with a high degree of acceptance, new to the market and of high clinical value, involving more than 10 clinical therapeutic areas of cancer, rare diseases, hepatitis, diabetes, multidrug-resistant tuberculosis, rheumatism and immunity, cardio-cerebral vascular and gastrointestinal, and the national unified payment standards. A number of "expensive drugs" to open the civilian price, the above negotiation success of the drugs collectively referred to as negotiated drugs, into the basic medical insurance fund payment. The negotiated medicines in Shandong Province are included in the payment of major illness insurance, which is audited and paid for by commercial insurance companies.
Consultation: How are the negotiated drugs reimbursed?
Participants using the implementation of "dual-channel" management of the 103 kinds of national negotiated drugs (including 16 kinds of reference to the negotiated drugs management of Class B drugs), should be "three" medical institutions responsible for physicians in accordance with the needs of the insured person's condition and the national drug catalog. The physician in charge of the "three designated" medical institution shall fill in the "Yantai City Negotiated Drugs Use Audit Form" (hereinafter referred to as the "Audit Form") according to the needs of the participant's condition and the limited scope of payment stipulated in the National Drug Catalog, and the reimbursement shall be made only after it is audited and recorded by the medical insurance department of the medical institution. With the Audit Form and the prescription of the responsible physician, the insured person can purchase and use the drugs in the designated medical institutions or "dual-channel" designated retail pharmacies. The validity period of each filing is half a year. Participants who still need the medicine after the expiration of the validity period and meet the payment conditions of the medical insurance can continue to apply for the medicine; if the medicine does not meet the payment conditions, the cost will be borne by the individual. The costs incurred by the participants of the charitable gift of drugs, the health insurance fund will not pay.
Outpatient chronic disease patients with medication: according to the outpatient chronic disease related reimbursement policy. Participants in the non-individual chronic disease designated "three" medical institutions, special drug retail pharmacies incurred outpatient negotiated drug costs, personal full advance to the chronic disease designated medical institutions on behalf of the reimbursement. The subsequent will gradually open the special drug designated retail pharmacy direct settlement.
Outpatient medication protection mechanism for the use of medication: outpatient use of insured employees, individuals in accordance with the prescribed proportion of out-of-pocket payment after the portion of the cost of complying with the medication, by the medical insurance fund at a rate of 80% payment. For outpatient use by insured residents, the portion of the cost of compliant medicines after individual out-of-pocket payment in accordance with the prescribed proportion, the first and second class contributions are paid by the residents' medical insurance fund at the proportion of 40% and 60% respectively. Participants in the "three" medical institutions, special drugs retail pharmacy outpatient negotiated drug costs, temporarily by the audit of the medical institutions responsible for reimbursement of the record, and will gradually open the special drugs designated retail pharmacy direct settlement.
Participants hospitalized in the use of negotiated drugs, after the audit for the record, in accordance with the relevant policies of hospitalization settlement. During the hospitalization period due to the shortage of medical institutions, the hospital health insurance department agreed and registered, in other "three" medical institutions, special drugs retail pharmacies, the negotiated drug costs incurred in the "dual-channel" medical institutions are responsible for the medical institutions combined with hospitalization costs and settlement.
What does the record price of a drug mean?
The record price of a drug is the selling price of the drug registered by the Drug Administration, usually refers to the retail price
Drug destruction filing process?
1, destruction declaration
After the approval of the Finance Department, has been made to confirm the expiration date of substandard drugs and has been made to report the loss of broken drugs and their packaging, to be regularly cleaned up and centralized destruction. Before the centralized destruction, the quality control department should supervise the warehouse management department to fill in the "Drug Destruction Declaration Form" and attached to the "end-of-life drug schedule", these two forms reported to the general manager for approval to the Pharmacy and Drug Administration, the Tax Bureau to declare. Before the approval shall not self-destruction.
2, the destruction cycle
In order to clean up the warehouse in a timely manner does not cause the accumulation of waste products, occupying the site, at least once a year to carry out the centralized destruction of end-of-life drugs. During this period, the Drug Administration has a unified action requirements, according to the unified deployment of the implementation.
3, destruction and monitoring
Pharmaceuticals in the warehouse before the destruction, under the supervision of the Quality Control Department of the physical inventory of drugs to prevent the loss of substandard drugs leading to safety accidents and other undesirable consequences; destruction of the treatment must be in the guidance of the Drug Administration, under the supervision of the consideration of the prevention of environmental contamination, away from urban areas and populated areas and the wind, the water upstream; to take the mashing, incineration, burial and other effective measures to destroy the problem of not leaving any consequences. Effective measures for destruction. Quality Control Department from the warehouse to the end of the destruction of the whole monitoring.
4, destruction records
The process of destruction of the above end-of-life drugs, the Quality Control Department to monitor all aspects of accurate records and sign. Audit, approval of the original submitted to the Finance Department for write-off vouchers; Quality Control Department is responsible for copies and the whole process of recording the documents and information, organized and archived within three days after the incident, the retention period of not less than three years.
What is the meaning of the drug and equipment production record number?
It is the record number of medical devices allowed to produce, not the record number of drugs. Medical devices are instruments, equipment, apparatus, in vitro diagnostic reagents and calibrators, materials and other similar or related items used directly or indirectly in the human body, including the required computer software.
Medical devices include medical equipment and medical consumables. Efficacy is obtained primarily by physical and other means, not by pharmacological, immunological or metabolic means, or although these means are involved but only in an ancillary manner.
Medical device industry involves medicine, machinery, electronics, plastics and other industries, is a multidisciplinary cross, knowledge-intensive, capital-intensive high-tech industry. And the basic characteristics of high-tech medical equipment is digital and computerized, is multi-disciplinary, cross-field crystallization of modern high technology.